Microbot Medical files prospectus supplement for existing ATM program with H.C. Wainwright

Microbot Medical Inc.

Company files prospectus supplement for ATM program with Wainwright; aggregate offering price up to $39,230,691.
Sales Agreement originally dated June 10, 2021, amended July 1, 2024.
Opinion of Mintz Levin regarding validity of ATM Shares filed as Exhibit 5.1.
No actual sales reported; program previously disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.